Product Details
1. The assay is to provide medical evidence for the etiology of
infertility, the prediction of
assisted reproductive pregnancy outcome and abortion.
2. Test by flow cytometry. Only take 2 minutes to test 1 sample.
3. Report with dual parameters
- Sperm DNA fragmentation index (DFI)
- High staining stainable (HDS)
4. The amount of tested sperm is big and ensure accurate result.
5. Standardized template report. With quick report.
Company Profile

BRED Life Science Technology Inc. specializes in developing, manufacturing and marketing
lab products in the field of reproductive medicine, offering
automatic assay platform and related products for infertility
diagnosis and ART treatment. Based on the test methods and standard
recommended by the World Health Organization, BRED develops serial
products for infertility diagnosis and ART treatment with
innovative technology. And these help promote the establishment and
popularization of standardization for reproductive medicine lab.
BRED own a completest range of relative products in the field of
reproductive medicine worldwide.The products are of independent
intellectual property right within BRED.
Our mission of development is to be devoted to providing the best
solutions and products for the clinical laboratory in reproductive
medicine with the aim to promote the development of human
reproductive health.
Our operating philosophy is putting people first, doing business on
the basis of honesty, forging ahead and working with diligence.
Welcome to visit our official website: www.spermfunc.com
